DUBLIN, Nov. 1, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) a leading global pharmaceutical company, today announced that Brent Saunders, Allergan's Chairman, CEO and President, will participate in a fireside chat at the Credit Suisse 25 th Annual Healthcare Conference on Tuesday, November 8, 2016 at 9:00 a.m. MT ( 11:00 a.m. ET) at The Phoenician in Scottsdale, Arizona. Logo - http://photos.prnewswire.com/prnh/20150612/222796LOGO The presentation will be webcast live and can be accessed on Allergan's Investor Relations web site at http://ir.allergan.com. The webcast can also be accessed through the following URL: https://cc.talkpoint.com/cred001/110716a_as/?entity=36_NOH6WSI. An archived version will be available approximately two hours after the live presentation ends and can be accessed at the same locations for 180 days. About Allergan plc Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model - Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories. Allergan is an industry leader in Open Science, the Company's R&D model, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. This approach has led to Allergan building one of the broadest development pipelines in the pharmaceutical industry with 70+ mid-to-late stage pipeline programs in development. Our Company's success is powered by our more than 16,000 global colleagues' commitment to being Bold for Life. Together, we build bridges, power ideas, act fast and drive results for our customers and patients around the world by always doing what is right.